Authors
Elen CT Landucci, Rogerio C Castro, Maristela F Pereira, Adelia CO Cintra, Jose R Giglio, Sergio Marangoni, Benedito Oliveira, Giuseppe Cirino, Edson Antunes, Gilberto De Nucci
Publication date
1998/2/19
Journal
European Journal of Pharmacology
Volume
343
Issue
2-3
Pages
257-263
Publisher
Elsevier
Description
Bothropstoxin-I and bothropstoxin-II are phospholipase A2 homologues isolated from Bothrops jararacussu snake venom. The former is devoid of phospholipase A2 activity whereas the latter has very low enzymatic activity. In this study, we have investigated the in vivo (rat paw and skin oedema) and in vitro (mast cell degranulation) inflammatory effects caused by bothropstoxin-I and bothropstoxin-II. Bothropstoxin-I (25–100 μg/paw) and bothropstoxin-II (12.5–50 μg/paw) caused dose-dependent rat paw oedema. The intradermal injection of bothropstoxin-I (0.125–5 μg/site) and bothropstoxin-II (0.125–5 μg/site) into rat skin also resulted in dose-dependent oedema formation. These oedematogenic activities were largely reduced in animals pretreated with the histamine/5-hydroxytryptamine (5-HT) receptor antagonist cyproheptadine (2 mg/kg, i.p. 0.5 h before). Similarly, p-bromophenacyl bromide, a compound …
Total citations
199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202316389354361010131655310431432
Scholar articles